On July 26, we celebrate the 33rd anniversary of the signing of the Americans with Disabilities Act (ADA). Passed in 1990, the ADA is a landmark civil rights law that promotes inclusion and prohibits discrimination against people with disabilities.
Against a backdrop of rising global inequality, Paris 2024 has a vision for “wide open” Games designed to spread opportunities and maximise the benefits for the long-term unemployed, small businesses and deprived communities.
Illumina and Pillar Biosciences Inc., the pioneers of Decision Medicine™, announced a strategic partnership to make Pillar's suite of oncology assays commercially available globally as part of the Illumina portfolio of oncology products.
As World Refugee Day focuses the world’s attention on the plight of the millions of displaced people around the world, the Olympic Refuge Foundation is working to ensure that, when those who have experienced crisis access sport, they do so in a safe and supportive environment.
A cornerstone of the Olympic Movement is the belief that sport has the power to bridge divides and promote harmony among people from diverse backgrounds.
We are honored to be included in Forbes lists for America’s Best Midsize Employer and America’s Best Employers for Diversity 2023. To have our workplace and culture recognized by our own employees and peers across our industry is demonstrative of the amazing workplace.
We will continue to partner with NNEDV and the Coalition Against Stalkerware to help more victims and survivors, as well as advocates, get the resources they need to address domestic violence and feel safer.
Learning new digital skills benefits women across all industries, not just those pursuing tech careers. Studies have shown that digitalization is a key driver of economic opportunity for women in India.
Comprehensive genomic profiling (CGP) assesses hundreds of tumor genes to find actionable mutations and is becoming the standard of care for many cancers. However, oncologists often opt for single-gene tests (SGT) before pursuing CGP.
